ClinicalTrials.gg
Not yet recruitingNCT07437092Updated Mar 2, 2026

Facilitating Psychological Closure and Emotional Change Through Mindfulness Meditation

An interventional study of Mindfulness Meditation and Mind-Wandering Task in Unresolved Event Memories and Psychological Closure, sponsored by University of Windsor. Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-02.

Sponsored by University of Windsor · Not applicable, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
220
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn if mindfulness meditation can improve closure and emotion towards unresolved memories in an undergraduate student population. This will be tested through a brief, novel intervention called Mindful Recollection, where participants transition immediately from mindfulness meditation into the recollection of an unresolved memory. The secondary aim of the study is to investigate the mechanisms of change underlying Mindful Recollection. Overall then, the main questions this study aims to answer are:

  • Does mindful recollection reduce negative emotions associated with unresolved event memories?
  • Can increases in acceptance, decentering, and reappraisal account for the observed effects of mindful recollection on negative emotion?
  • Does mindful recollection facilitate closure towards unresolved event memories?
  • Can increases in acceptance, decentering, and reappraisal account for the observed effects of mindful recollection on closure?

Researchers will compare the Mindful Recollection intervention to a mind-wandering control task to see if mindfulness meditation uniquely produces positive changes in emotion and closure above and beyond placebo. Mindful Recollection will involve a 13-minute audio-guided mindfulness meditation followed immediately by 2 minutes of memory recollection. The control task will involve 13-minutes of audio-guided mind-wandering followed immediately by 2 minutes of memory recollection.

Participants will:

  • Complete pretest measures of emotion and closure towards an unresolved event memory.
  • Engage in either the Mindful Recollection intervention or the placebo control task after a 24-72 hour delay.
  • Complete post-test measures of emotion and closure towards the same unresolved event memory.
02

Conditions studied

  • Unresolved Event Memories
  • Psychological Closure

Keywords

  • Unresolved memories
  • Psychological closure
  • Closure
  • Mindfulness meditation
03

In context

Lead sponsor

University of Windsor is the lead sponsor of 9 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Ability to hear and understand spoken instructions clearly; English language proficiency

Exclusion criteria

Exclusion Criteria:

  • Trauma history/Dissociative tendencies
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
220 participants (estimated)

Study arms

  • Experimental
    Mindful Recollection

    Behavioral: Mindfulness Meditation

  • Sham comparator
    Mind-Wandering

    Behavioral: Mind-Wandering Task

Interventions

  • BehavioralMindfulness Meditation

    Mindful Recollection consists of a 15-minute audio-guided task (13 minutes of guided meditation followed immediately by 2 minutes of unresolved event recollection). The 13-minute guided meditation is intended to facilitate a broad mindful awareness by working through sensations of the breath, body, and mind (in that respective order), eventually coming together in a practice of open monitoring - the non-selective observation of any and all aspects of experience. The 2-minute recollection period will have participants transition from meditating to recalling and reflecting on an unresolved memory they identified during the pretest period (approximately 24-72 hours prior).

  • BehavioralMind-Wandering Task

    The mind-wandering control task consists of a 15-minute audio-guided task (13 minutes of mind-wandering followed immediately by 2 minutes of unresolved event recollection). Mind-wandering is a common sham mindfulness technique that repeatedly prompts participants to let their thoughts flow freely, thinking about whatever comes to mind. This exposes participants to the same procedure (i.e., listening to a 13-minute audio-recording) without receiving guided mindful meditation instructions. Thus, this condition will guide participants to have a typical mental experience of thinking freely about whatever comes to mind, without developing a mindful awareness of their internal experience.

06

What researchers measure

Primary outcomes

  1. Pre- to Post-Test Changes in Psychological Closure using the Closure and Resolution Scale (CRS)

    Items are rated on a 7-point Likert scale (1 = Completely disagree, 7 = Completely agree), with higher scores reflecting greater levels of closure and resolution.

    Time frame: Baseline (24-72 hours prior to the intervention) and post-test (immediately after intervention)

  2. Pre- to Post-Test Changes in Negative Emotion using the Positive and Negative Affect Schedule (PANAS)

    Items are rated on a 5-point Likert scale (1 = Not at all, 5 = Extremely), with higher scores reflecting a stronger endorsement of that emotional experience.

    Time frame: Baseline (24-72 hours prior to the intervention) and post-test (immediately after intervention)

Secondary outcomes

  1. Experiential Acceptance Towards Thoughts and Emotions

    Using the acceptance subscale of The Southampton Experiential Avoidance and Acceptance Scale. Items are rated on a 7-point Likert scale (1 = Strongly disagree, 7 = Strongly agree), with higher scores indicating greater levels of openness towards internal experience.

    Time frame: Immediately after the intervention (post-test)

  2. Reappraisal

    Using the Regulation of Emotion Systems Survey. Items are rated on a 5-point Likert scale (1 = Strongly disagree, 5 = Strongly agree), with higher scores indicating greater engagement in reappraisal during the assigned task.

    Time frame: Immediately after the intervention (post-test)

  3. State Decentering

    Using the Metacognitive Processes of Decentering-state scale. Items are rated on an 11-point Likert scale (0 = Not at all, 10 = Very much), with higher scores reflecting greater levels of state decentering (i.e., being aware of, disidentified with, and nonreactive to thoughts and emotions).

    Time frame: Immediately after the intervention (post-test)

Other outcomes

  1. Memory Characteristics

    Using the Memory Experience Questionnaire Short-Form. Measures distinct qualities of autobiographical memory (e.g., coherence, vividness, visual perspective). Items are rated on a 5-point Likert scale (1 = Strongly disagree, 5 = Strongly agree), with higher scores indicating greater endorsement of a given memory characteristic.

    Time frame: Immediately after the intervention (post-test)

  2. State Mindfulness (Manipulation Check)

    Using the State Mindfulness Scale. Administered as a manipulation check to measure participants' reports of mindful states during the assigned tasks. Items are rated on a 5-point Likert scale (1 = Not at all, 5 = Very well), with higher scores indicating greater states of mindfulness.

    Time frame: Immediately after the intervention (post-test)

07

Study locations

1 site
08

References and documents

Publications

  • Luchetti M, Sutin AR. Measuring the phenomenology of autobiographical memory: A short form of the Memory Experiences Questionnaire. Memory. 2016;24(5):592-602. doi: 10.1080/09658211.2015.1031679. Epub 2015 Apr 20. PubMed 25894806 ↗
  • De France, K., & Hollenstein, T. (2017). Assessing emotion regulation repertoires: The Regulation of Emotion Systems Survey. Personality and Individual Differences, 119, 204-215. https://doi.org/10.1016/j.paid.2017.07.018
  • McAndrews, Z., Hart, C. M., & Stopa, L. (2024). Development of the Southampton Experiential Avoidance and Acceptance Scale (SEAAS). Journal of Contextual Behavioral Science, 33, 100822-. https://doi.org/10.1016/j.jcbs.2024.100822
  • Tanay G, Bernstein A. State Mindfulness Scale (SMS): development and initial validation. Psychol Assess. 2013 Dec;25(4):1286-99. doi: 10.1037/a0034044. Epub 2013 Sep 23. PubMed 24059475 ↗
  • Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063. PubMed 3397865 ↗
  • Hanley AW, Bernstein A, Nakamura Y, Hadash Y, Rojas J, Tennant KE, Jensen RL, Garland EL. The Metacognitive Processes of Decentering Scale: Development and initial validation of trait and state versions. Psychol Assess. 2020 Oct;32(10):956-971. doi: 10.1037/pas0000931. Epub 2020 Jul 23. PubMed 32700920 ↗
  • Boucher CM, Scoboria A, Soucie K, Pascual-Leone A. Development and validation of the Closure and Resolution Scale (CRS). Memory. 2025 Feb;33(2):205-222. doi: 10.1080/09658211.2024.2427666. Epub 2024 Nov 19. PubMed 39561135 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Mar 2026; primary completion for Aug 2027, 17 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 20, 2026
First posted
Feb 27, 2026
StartEst.
Mar 2026
Primary completionEst.
Aug 2027
CompletionEst.
Aug 2027
Last update
Mar 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07437092
Lead sponsor
University of Windsor
Responsible party
Anas Alsayed Hasan (MA Student, University of Windsor) — Principal investigator
First posted
Feb 27, 2026
Start date
Mar 2026 (estimated)
Primary completion
Aug 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Mar 2, 2026

Study contacts

Anas Alsayed Hasan
Contact
alsayed4@uwindsor.ca
647-224-1595

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion